144 related articles for article (PubMed ID: 21126805)
21. The rationale and evidence base for the direct removal of serum-free light chains in the management of myeloma kidney.
Cockwell P; Cook M
Adv Chronic Kidney Dis; 2012 Sep; 19(5):324-32. PubMed ID: 22920643
[TBL] [Abstract][Full Text] [Related]
22. [Detection of free light chains--a new method of diagnostics of haematological diseases].
Mecl J; Benáková H; Nohejlová A; Straub J; Zima T; Spicka I
Cas Lek Cesk; 2007; 146(2):159-62. PubMed ID: 17373113
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness of Haemodiafiltration with Heat Sterilized High-Flux Polyphenylene HF Dialyzer in Reducing Free Light Chains in Patients with Myeloma Cast Nephropathy.
Rousseau-Gagnon M; Agharazii M; De Serres SA; Desmeules S
PLoS One; 2015; 10(10):e0140463. PubMed ID: 26466100
[TBL] [Abstract][Full Text] [Related]
24. Screening panels for detection of monoclonal gammopathies: confidence intervals.
Pretorius CJ; Ungerer JP; Wilgen U; Klingberg S
Clin Chem; 2010 Apr; 56(4):677-9; author reply 679-80. PubMed ID: 20110450
[No Abstract] [Full Text] [Related]
25. The relationship between the serum free light chain assay and serum immunofixation electrophoresis, and the definition of concordant and discordant free light chain ratios.
Singhal S; Vickrey E; Krishnamurthy J; Singh V; Allen S; Mehta J
Blood; 2009 Jul; 114(1):38-9. PubMed ID: 19411633
[TBL] [Abstract][Full Text] [Related]
26. Myeloma kidney: advances in molecular mechanisms of acute kidney injury open novel therapeutic opportunities.
Davenport A; Merlini G
Nephrol Dial Transplant; 2012 Oct; 27(10):3713-8. PubMed ID: 23114897
[TBL] [Abstract][Full Text] [Related]
27. Light chains removal by extracorporeal techniques in acute kidney injury due to multiple myeloma: a position statement of the Onconephrology Work Group of the Italian Society of Nephrology.
Fabbrini P; Finkel K; Gallieni M; Capasso G; Cavo M; Santoro A; Pasquali S
J Nephrol; 2016 Dec; 29(6):735-746. PubMed ID: 27757797
[TBL] [Abstract][Full Text] [Related]
28. Specificity of serum and urine protein electrophoresis for the diagnosis of monoclonal gammopathies.
Katzmann JA; Stankowski-Drengler TJ; Kyle RA; Karen SL; Snyder MR; Lust JA; Dispenzieri A
Clin Chem; 2010 Dec; 56(12):1899-900. PubMed ID: 20844060
[No Abstract] [Full Text] [Related]
29. Assessment of the diagnostic performances of IgA heavy and light chain pairs in patients with IgA monoclonal gammopathy.
Wolff F; Debaugnies F; Rozen L; Willems D; Brohet F; Brauner J; Stordeur P
Clin Biochem; 2013 Jan; 46(1-2):79-84. PubMed ID: 23041246
[TBL] [Abstract][Full Text] [Related]
30. Poor performance of the total kappa/lambda light chain quantification in the diagnosis and follow-up of patients with multiple myeloma.
Zamora-Ortiz G; Velázquez-Sánchez-de-Cima S; Hernández-Reyes J; Martagón-Herrera NA; Ruiz-Argüelles A; Ruiz-Delgado GJ; Ruiz-Argüelles GJ
Rev Invest Clin; 2014; 66(4):314-8. PubMed ID: 25695296
[TBL] [Abstract][Full Text] [Related]
31. Treatment by long haemodialysis sessions with high cut-off filters in myeloma cast nephropathy: our experience.
Borrego-Hinojosa J; Pérez-del Barrio MP; Biechy-Baldan Mdel M; Merino-García E; Sánchez-Perales MC; García-Cortés MJ; Ocaña-Pérez E; Gutiérrez-Rivas P; Liébana-Cañada A
Nefrologia; 2013; 33(4):515-23. PubMed ID: 23897183
[TBL] [Abstract][Full Text] [Related]
32. [Clinical value of the blood measurement of the free light chains of immunoglobulins].
Bidet A; Marit G; Bérard AM
Ann Biol Clin (Paris); 2008; 66(4):427-31. PubMed ID: 18725344
[TBL] [Abstract][Full Text] [Related]
33. Serum free light chains in the diagnosis and monitoring of patients with plasma cell dyscrasias.
Mayo MM; Johns GS
Contrib Nephrol; 2007; 153():44-65. PubMed ID: 17075223
[TBL] [Abstract][Full Text] [Related]
34. Laboratory testing in monoclonal gammopathy of renal significance (MGRS).
Leung N; Barnidge DR; Hutchison CA
Clin Chem Lab Med; 2016 Jun; 54(6):929-37. PubMed ID: 27107835
[TBL] [Abstract][Full Text] [Related]
35. Combined analysis using extended renal reference range of serum free light chain ratio and serum protein electrophoresis improves the diagnostic accuracy of multiple myeloma in renal insufficiency.
Park JW; Kim YK; Bae EH; Ma SK; Kim SW
Clin Biochem; 2012 Jul; 45(10-11):740-4. PubMed ID: 22503879
[TBL] [Abstract][Full Text] [Related]
36. IgD multiple myeloma: Clinical, biological features and prognostic value of the serum free light chain assay.
Djidjik R; Lounici Y; Chergeulaïne K; Berkouk Y; Mouhoub S; Chaib S; Belhani M; Ghaffor M
Pathol Biol (Paris); 2015 Sep; 63(4-5):210-4. PubMed ID: 26294067
[TBL] [Abstract][Full Text] [Related]
37. Renal improvement in myeloma with plasma exchange.
Hutchison C; Bridoux F; Fermand JP
N Engl J Med; 2011 Sep; 365(11):1061; author reply 1062. PubMed ID: 21916654
[No Abstract] [Full Text] [Related]
38. Replacing urine protein electrophoresis with serum free light chain analysis as a first-line test for detecting plasma cell disorders offers increased diagnostic accuracy and potential health benefit to patients.
McTaggart MP; Lindsay J; Kearney EM
Am J Clin Pathol; 2013 Dec; 140(6):890-7. PubMed ID: 24225758
[TBL] [Abstract][Full Text] [Related]
39. Detection of Plasma Cell Disorders by Mass Spectrometry: A Comprehensive Review of 19,523 Cases.
Dasari S; Kohlhagen MC; Dispenzieri A; Willrich MAV; Snyder MR; Kourelis TV; Lust JA; Mills JR; Kyle RA; Murray DL
Mayo Clin Proc; 2022 Feb; 97(2):294-307. PubMed ID: 34887112
[TBL] [Abstract][Full Text] [Related]
40. Optimization of utilization of serum protein analysis: role of the electronic medical record in promoting consultation by pathology.
Zia HM; Singh G
Am J Clin Pathol; 2013 Jun; 139(6):793-7. PubMed ID: 23690123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
